Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hyperphosphatemia in Chronic Kidney Disease”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00892749
What this trial is testing

Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis

Who this might be right for
Chronic Kidney DiseaseRenal DialysisRenal Insufficiency+1 more
Astellas Pharma Inc 248
Large-scale testing (Phase 3)Study completedNCT01324128
What this trial is testing

Investigate the Safety and Efficacy of PA21, a Phosphate Binder, in Dialysis Patients

Who this might be right for
Chronic Kidney Disease Requiring Chronic Dialysis
Vifor Pharma 1,059
Large-scale testing (Phase 3)Study completedNCT03644264
What this trial is testing

PA21 Safety and Efficacy in Adult Chinese Subjects

Who this might be right for
Chronic Kidney Disease Requiring Chronic DialysisHyperphosphatemia
Vifor Fresenius Medical Care Renal Pharma 286
Large-scale testing (Phase 3)Ended earlyNCT01818687
What this trial is testing

Safety and Tolerability Study of MCI-196

Who this might be right for
Chronic Kidney DiseaseNot on DialysisHyperphosphatemia+1 more
Tanabe Pharma Corporation 4
Not applicableStudy completedNCT01955876
What this trial is testing

Fosrenol Post-marketing Surveillance in Japan

Who this might be right for
HyperphosphatemiaKidney Disease
Bayer 343
Not applicableStudy completedNCT02755961
What this trial is testing

Efficacy of Dietary Education and Education on Phosphate Binder Use in Hemodialysis Patients

Who this might be right for
HyperphosphatemiaEnd-stage Renal Disease
Ajou University School of Medicine 70
Testing effectiveness (Phase 2)Study completedNCT01521494
What this trial is testing

PA21 Phase II Clinical Study in Hemodialysis Patients With Hyperphosphatemia

Who this might be right for
Chronic Kidney Disease Requiring Hemodialysis
Kissei Pharmaceutical Co., Ltd. 183
Post-approval studies (Phase 4)Ended earlyNCT02661295
What this trial is testing

Ferric Citrate to Improve Inflammation and Lipid Levels

Who this might be right for
End Stage Renal DiseaseHyperphosphatemiaChronic Inflammation
Winthrop University Hospital 38
Testing effectiveness (Phase 2)UnknownNCT00358046
What this trial is testing

Efficacy and Tolerability of ILY101 in Dialysis Patients With Hyperphosphatemia

Who this might be right for
Kidney DiseasesRenal Insufficiency
Ilypsa 120
Early research (Phase 1)Study completedNCT00458289
What this trial is testing

Efficacy of Phosphate Binding in Healthy Volunteers: Chewed Versus Crushed Lanthanum Carbonate

Who this might be right for
Hyperphosphatemia in Chronic Kidney Disease
University of Illinois at Chicago 12
Large-scale testing (Phase 3)Study completedNCT01187628
What this trial is testing

Long-term Study in Chronic Kidney Disease (Extension From Study 14817)

Who this might be right for
Hyperphosphatemia
Bayer 123
Not applicableLooking for participantsNCT06206135
What this trial is testing

Multicenter, Open, Prospective, 48 Weeks, Observational Study ,Evaluate the Safety and Efficacy of Nephoxil Capsule

Who this might be right for
Hyperphosphatemia
LG Chem 172
Testing effectiveness (Phase 2)Study completedNCT00660530
What this trial is testing

Chewed vs. Crushed Lanthanum Carbonate in Hemodialysis Patients

Who this might be right for
HyperphosphatemiaKidney Disease
University of Illinois at Chicago 11
Large-scale testing (Phase 3)Study completedNCT00506441
What this trial is testing

A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia

Who this might be right for
Chronic Kidney DiseaseDialysisHyperphosphatemia
Tanabe Pharma Corporation 245
Large-scale testing (Phase 3)Study completedNCT01017276
What this trial is testing

Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal Dialysis

Who this might be right for
Chronic Kidney DiseaseRenal DialysisRenal Insufficiency
Astellas Pharma Inc 35
Large-scale testing (Phase 3)Ended earlyNCT00844662
What this trial is testing

Phase III Study to Investigate the Safety and Efficacy of Fermagate and Sevelamer Hydrochloride

Who this might be right for
Chronic Kidney Failure
Ineos Healthcare Limited 1,000
Large-scale testing (Phase 3)UnknownNCT06406140
What this trial is testing

Study the Effect of Niacin on Lipoprotein (a) Concentration and Hyperphosphatemia in Hemodialysis Patients

Who this might be right for
End-stage Renal Disease
Al-Azhar University 50
Testing effectiveness (Phase 2)Study completedNCT04551300
What this trial is testing

Evaluate the Safety and Efficacy of VS-505(AP301) to Treat Hyperphosphatemia in Hemodialysis Patients

Who this might be right for
Hyperphosphatemia
Shanghai Alebund Pharmaceuticals Limited 158
Early research (Phase 1)Study completedNCT02510274
What this trial is testing

Single and Multiple Dosing Study in Hemodialysis Patients With Hyperphosphatemia in Japan

Who this might be right for
Chronic Kidney DiseaseHyperphosphatemia Undergoing Hemodialysis
Astellas Pharma Inc 24
Large-scale testing (Phase 3)Ended earlyNCT00841126
What this trial is testing

Phase III Study to Investigate the Safety and Efficacy of Fermagate and Lanthanum Carbonate

Who this might be right for
Chronic Kidney Failure
Ineos Healthcare Limited 657
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation